Association between nicotinamide phosphoribosyltransferase and de novo lipogenesis in nonalcoholic fatty liver disease

Objective: Jh//s study explored the association between serum nicotinamide phosphoribosyltransferase [NAMPT] and hepatic de novo lipogenesis [DNL] in nonalcoholic fatty liver disease [NAFLD] and determined whether or not this association is sex dependent

Subjects and Methods: In this cross-sectional study, 62 consecutive patients [32 males, 30 females] with NAFLD were recruited. Serum NAMPT [by ELI-SA], palmitic acid, and the DNL index of erythrocyte membranes as markers of hepatic DNL [by gas chromatography] were analyzed

The controlled attenuation parameter [CAP] and body impedance analyzer were used to assess hepatic and body fat respectively. Univariate and multiple linear regressions [to adjust for confounders] were used to analyze the association of serum NAMPT with palmitic acid, DNL index, CAP, and body fat

Results: The respective values of serum NAMPT [2.44 +/- 1.03 vs. 2.45 +/-1.13 ng/mL,p = 0.98], DNL index [3.11 [2.60-3.71 ] vs. 3.05 [2.40-3.59],p = 0.90], and pal-mitic acid [20.55% [15.34-24.04] vs. 22.64% [21.15-25.95], p = 0.07] were not significantly different between men and women, but those of CAP [326 [300-340] vs. 300 [261.25-329], p = 0.002] and body fat [37.71 +/- 3.80 vs. 26.60 +/- 5.70, p < 0.001] were significantly higher in women. In women, serum NAMPT had a significant negative association with the DNL index [p = -0.56, p = 0.01]. The DNL index also hada significant negative association with body fat [P = -0.46, p = 0.02]

In men, the only significant association was the positive association between serum NAMPT and CAP [p = 0.35, p = 0.035]

Conclusion: Higher serum NAMPT in women was associated with a lower hepatic DNL index, while in men it was associated with higher hepatic fat and had no association with the DNL index. Therefore, the serum NAMPT level interpretation for NAFLD prognosis is probably sex dependent

Prevalence of non-alcoholic fatty liver disease and its predictors in north of Iran

Nonalcoholic fatty liver disease [NAFLD] is one of the aspects of metabolic syndrome [MetS]. Due to the increase of MetS in Iran, this study was conducted to determine the prevalence of NAFLD, its potential predictors and their sex distribution in north of Iran, Amol. In 2008 this population based cross-sectional study included 5023 adult individuals who were randomly selected from Amol healthcare centers. Blood analysis and hepatic sonography was performed for each individual and Clinical histories were reviewed. MetS was defined according to the National Cholesterol Education Program Adult Treatment Panel III. Chi-square test, univariate and multivariate logistic regression were used to analyze data. The prevalence of NAFLD and metabolic syndrome was 43.8% and 29.6% respectively. Both NAFLD and metabolic syndrome were significantly more prevalent in women. There was a stronger association between these two factors in women which may indicate MetS has a much more potency to result in NAFLD in women. The strongest predictors of NAFLD in men were waist circumference>102 cm, serum ALT >/= 40 [U/L] and the age group of 40-60 years. The strongest predictors of NAFLD in women were waist circumference >88 cm, the age groups of 40-60 and >60 years. The observed prevalence is alarming because almost 7out of 10 subjects with MetS had NAFLD. As high waist circumference was an important predictor of NAFLD in both sexes, health care policies to reduce the incidence of obesity in the country will have an important impact on the occurrence of NAFLD